Stability of dexamethasone sodium phosphate in rat plasma

Por Samtani, Mahesh N., Jusko, William J.
Publicado em 2005

Comparison of Dexamethasone Pharmacokinetics in Female Rats after Intravenous and Intramuscular Administration

Por Samtani, Mahesh N., Jusko, William J.
Publicado em 2005

Quantification of dexamethasone and corticosterone in rat biofluids and fetal tissue using highly sensitive analytical methods: assay validation and application to a pharmacokineti...

Por Samtani, Mahesh N., Jusko, William J.
Publicado em 2007

Population Pharmacokinetics of Doripenem Based on Data from Phase 1 Studies with Healthy Volunteers and Phase 2 and 3 Studies with Critically Ill Patients

Por Nandy, Partha, Samtani, Mahesh N., Lin, Rachel
Publicado em 2010

Pharmacokinetic-Pharmacodynamic-Model-Guided Doripenem Dosing in Critically Ill Patients

Por Samtani, Mahesh N., Flamm, Robert, Kaniga, Koné, Nandy, Partha
Publicado em 2010

Variations in the FRA10AC1 Fragile Site and 15q21 Are Associated with Cerebrospinal Fluid Aβ(1-42) Level

Por Li, Qingqin S., Parrado, Antonio R., Samtani, Mahesh N., Narayan, Vaibhav A.
Publicado no PLoS One (2015)

Disease progression model for Clinical Dementia Rating–Sum of Boxes in mild cognitive impairment and Alzheimer’s subjects from the Alzheimer’s Disease Neuroimaging Initiative

Por Samtani, Mahesh N, Raghavan, Nandini, Novak, Gerald, Nandy, Partha, Narayan, Vaibhav A
Publicado em 2014

Kinetics of Betamethasone and Fetal Cardiovascular Adverse Effects in Pregnant Sheep After Different Doses

Por Schwab, Matthias, Coksaygan, Turhan, Samtani, Mahesh N., Jusko, William J., Nathanielsz, Peter W.
Publicado em 2006

BETAMETHASONE PHARMACOKINETICS AFTER TWO PRODRUG FORMULATIONS IN SHEEP: IMPLICATIONS FOR ANTENATAL CORTICOSTEROID USE

Por Samtani, Mahesh N., Löhle, Matthias, Grant, Angela, Nathanielsz, Peter W., Jusko, William J.
Publicado em 2005

Doripenem Dosing Recommendations for Critically Ill Patients Receiving Continuous Renal Replacement Therapy

Por Samtani, Mahesh N., Vaccaro, Nicole, Cirillo, Iolanda, Matzke, Gary R., Redman, Rebecca, Nandy, Partha
Publicado em 2012

Expansion of guidance for the day 8 initiation dose of paliperidone palmitate to avoid a missed dose

Por Samtani, Mahesh N, Nuamah, Isaac, Gopal, Srihari, Remmerie, Bart, Kern Sliwa, Jennifer, Alphs, Larry
Publicado em 2013

Pharmacodynamic Profiling of Ceftobiprole for Treatment of Complicated Skin and Skin Structure Infections

Por Kimko, Holly, Xu, Xu, Nandy, Partha, Samtani, Mahesh N., Strauss, Richard S., Bagchi, Partha, Noel, Gary J.
Publicado em 2009

Management of antipsychotic treatment discontinuation and interruptions using model-based simulations

Por Samtani, Mahesh N, Sheehan, John J, Fu, Dong-Jing, Remmerie, Bart, Sliwa, Jennifer Kern, Alphs, Larry
Publicado em 2012

Population Pharmacokinetics of Paliperidone Palmitate (Once‐Monthly Formulation) in Japanese, Korean, and Taiwanese Patients With Schizophrenia

Por Shimizu, Hiroko, Neyens, Martine, De Meulder, Marc, Gopal, Srihari, Tsukamoto, Yuko, Samtani, Mahesh N., Remmerie, Bart
Publicado no Clin Pharmacol Drug Dev (2019)

The ADAS-Cog revisited: Novel composite scales based on ADAS-Cog to improve efficiency in MCI and early AD trials

Por Raghavan, Nandini, Samtani, Mahesh N., Farnum, Michael, Yang, Eric, Novak, Gerald, Grundman, Michael, Narayan, Vaibhav, DiBernardo, Allitia
Publicado em 2012

A one-year prospective study of the safety, tolerability and pharmacokinetics of the highest available dose of paliperidone palmitate in patients with schizophrenia

Por Coppola, Danielle, Liu, Yanning, Gopal, Srihari, Remmerie, Bart, Samtani, Mahesh N, Hough, David W, Nuamah, Isaac, Sulaiman, Ahmad, Pandina, Gahan
Publicado em 2012

Disease progression model in subjects with mild cognitive impairment from the Alzheimer's disease neuroimaging initiative: CSF biomarkers predict population subtypes

Por Samtani, Mahesh N, Raghavan, Nandini, Shi, Yingqi, Novak, Gerald, Farnum, Michael, Lobanov, Victor, Schultz, Tim, Yang, Eric, DiBernardo, Allitia, Narayan, Vaibhav A
Publicado em 2013

Prospective dose selection and acceleration of paliperidone palmitate 3‐month formulation development using a pharmacometric bridging strategy

Por Samtani, Mahesh N., Nandy, Partha, Ravenstijn, Paulien, Remmerie, Bart, Vermeulen, An, Russu, Alberto, D'hoore, Peter, Baum, Ellen Z., Savitz, Adam, Gopal, Srihari, Hough, David
Publicado no Br J Clin Pharmacol (2016)

Alzheimer's disease assessment scale-cognitive 11-item progression model in mild-to-moderate Alzheimer's disease trials of bapineuzumab

Por Samtani, Mahesh N., Xu, Steven X., Russu, Alberto, Adedokun, Omoniyi J., Lu, Ming, Ito, Kaori, Corrigan, Brian, Raje, Sangeeta, Brashear, H. Robert, Styren, Scot, Hu, Chuanpu
Publicado no Alzheimers Dement (N Y) (2015)

Alzheimer's disease progression model using disability assessment for dementia scores from bapineuzumab trials

Por Xu, Steven X., Samtani, Mahesh N., Russu, Alberto, Adedokun, Omoniyi J., Lu, Ming, Ito, Kaori, Corrigan, Brian, Raje, Sangeeta, Brashear, H. Robert, Styren, Scot, Hu, Chuanpu
Publicado no Alzheimers Dement (N Y) (2015)